Latest News

The companies are competing for a share of India’s Semaglutide market, which analysts estimate will reach USD1 billion over the next two years.

The new facility operates as a fully smart, digital-first outpatient center that connects appointments, consultations, diagnostics, pharmacy services, and follow-up care through integrated digital systems.

This transaction grants Collegium a second branded ADHD medication to complement its existing Jornay PM offering.

Psoriasis is a chronic autoimmune disorder in which skin cells multiply excessively, creating thick, itchy, scaly patches that affect more than 8 million Americans.

Novartis will direct the funds toward upgrading its manufacturing plant in Beijing and expanding its R&D campus in Shanghai, where it also houses its Chinese headquarters.

The transaction, which remains subject to customary regulatory approvals, marks the beginning of what both firms describe as Syntegon’s next major growth phase.

The partnership will provide JOOTRH with dedicated advanced facilities, including project-specific space for an Advanced Pathology Lab within the hospital.

Construction crews have already broken ground on the expansion project, which Axplora expects to complete by February 2027.

The alert followed official communication from Roche Nigeria after the pharmaceutical company received multiple complaints from healthcare professionals nationwide.

The upgraded complex features modern operating theatres, an intensive care unit (ICU), a high-dependency unit (HDU), and dedicated teaching spaces that enhance both patient care and medical training.